Enveda Biosciences logo

Enveda Biosciences

Emerging

Enveda Biosciences uses AI, metabolomics, and robotics to mine natural products for novel drug candidates; platform identifies chemical structure and activity from complex biological samples; raised $51M Series B in 2023;

Best for: Natural Product Drug Discovery — AI & Metabolomics PlatformEmerging, rapid growth
36
AI Score
Grade D
AI Visibility Score (Beta)
Life Sciences & BioTechNatural Product Drug Discovery — AI & Metabolomics PlatformWebsiteUpdated October 2026

Company Overview

About Enveda Biosciences

Enveda Biosciences is a drug discovery company founded in 2020 and headquartered in Boulder, Colorado, that is revitalizing natural product chemistry as a source of novel pharmaceutical compounds using modern AI and metabolomics. Natural products — molecules produced by plants, fungi, bacteria, and other organisms — have historically been the origin of over 60% of approved drugs, including penicillin, aspirin, morphine, and paclitaxel. However, traditional natural product discovery was slow, requiring isolation and purification of individual compounds from complex biological mixtures before testing. Enveda's platform eliminates this bottleneck by using mass spectrometry, machine learning, and robotics to identify the chemical structure, biological activity, and function of molecules directly from complex natural samples — without requiring isolation of individual compounds first.

Business Model & Competitive Advantage

Enveda's platform ingests data from thousands of natural samples, maps the chemical space of each using metabolomics and MS/MS fragmentation data, and applies AI models to predict molecular structure, prioritize candidates by predicted biological activity, and identify which molecules are most likely to become tractable drug leads. The company raised a $51M Series B in 2023 led by Kinnevik and The Engine (MIT's deep tech fund), with previous participation from investors including Khosla Ventures. Enveda's therapeutic pipeline targets infectious diseases and neurological conditions — areas with high unmet need and historical precedent for natural product-derived drugs.

Competitive Landscape 2025–2026

Enveda operates in the intersection of AI drug discovery and natural product chemistry — a combination that addresses one of the industry's most neglected sources of chemical novelty. While AI drug discovery has attracted billions in investment targeting known protein targets with synthetic compounds, Enveda's approach opens access to a largely unexplored chemical universe with billions of structurally diverse natural compounds — many of which have been shaped by billions of years of evolutionary pressure to interact with biological targets.

Founded
2020
Headquarters
Boulder, Colorado
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Enveda Biosciences is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

36
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

Saluda Medical logo

Saluda Medical

Life Sciences & BioTech
HealthtechHardwareB2bGlobalStartupAi Powered

Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Karius logo

Karius

Life Sciences & BioTech
HealthtechAi PoweredB2bEnterpriseNorth AmericaTechnologyAnalytics

Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

For Enveda Biosciences

Claim This Profile

Are you from Enveda Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Enveda Biosciences Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Enveda Biosciences vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →